SPRB · NASDAQ · Biotechnology

Spruce Biosciences (SPRB)

Develops an enzyme therapy for Sanfilippo syndrome and a preclinical CAH antibody.

$59.00
Pre-market−0.68 (−1.14%)
At close$59.68(+7.34%)

Breakdown13F · 13D/G · Form 4

Institutions32 holders · as of Mar 31, 202625.74%739.8K shares
Insiders5 holders · as of Jul 27, 20269.77%280.9K shares
Strategic holders1 holder · as of Oct 8, 20250.04%1.1K shares
Otherremainder64.45%1.85M shares

2.87M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Orin HirschmanInsider
8.70%250,00013Gfiled Jul 27, 2026
AWM Investment Company, Inc.Institution
5.11%146,98813Gfiled Aug 14, 2026
Ikarian Capital, LLCInstitution
4.22%121,35613Fas of Mar 31, 2026
Millennium Management LLCInstitution
3.89%111,88813Fas of Mar 31, 2026
Citadel Advisors LLCInstitution
2.44%69,99913Fas of Mar 31, 2026
Adar1 Capital Management, LLCInstitution
2.04%58,60013Fas of Mar 31, 2026
Alyeska Investment Group, L.P.Institution
1.80%51,67113Fas of Mar 31, 2026
Wellington Management Group LLPInstitution
1.70%48,79613Fas of Mar 31, 2026
Boothbay Fund Management, LLCInstitution
1.46%42,08013Fas of Mar 31, 2026
Balyasny Asset Management L.P.Institution
1.39%40,00013Fas of Mar 31, 2026
Carlyle Group Inc.Institution
1.34%38,62013Fas of Mar 31, 2026
Quinn Opportunity Partners LLCInstitution
0.93%26,81013Fas of Mar 31, 2026
Exoduspoint Capital Management, LPInstitution
0.77%22,00013Fas of Mar 31, 2026
Javier B. SzwarcbergInsiderdirector, officer: CHIEF EXECUTIVE OFFICER
0.67%19,270Form 4filed Jul 9, 2026
Vanguard Capital Management LLCInstitution
0.64%18,33713Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.59%16,93813Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
0.45%12,88913Fas of Mar 31, 2026
Squadron Capital Management LLCInstitution
0.42%12,20013Fas of Mar 31, 2026
Diadema Partners LPInstitution
0.35%10,00013Fas of Mar 31, 2026
Samir M. GharibInsiderofficer: PRESIDENT AND CFO
0.29%8,263Form 4filed Dec 17, 2025
Stempoint Capital LPInstitution
0.22%6,36013Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.19%5,51413Fas of Mar 31, 2026
Goldman Sachs Group IncInstitution
0.19%5,50613Fas of Mar 31, 2026
State Street CorpInstitution
0.19%5,40013Fas of Mar 31, 2026
Resolute Capital Asset Partners LLCInstitution
0.14%4,00013Fas of Mar 31, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

32 holders · 739.8K shares · 10 new positions · 16 increased · 6 reduced · 10 closed

HolderShares% outstandingChg q/qFiled
Ikarian Capital, LLC121.4K4.22%0May 15, 2026
Millennium Management LLC111.9K3.89%+111.9KnewMay 15, 2026
Citadel Advisors LLC70.0K2.44%0May 15, 2026
Adar1 Capital Management, LLC58.6K2.04%+600May 18, 2026
Alyeska Investment Group, L.P.51.7K1.80%0May 15, 2026
Wellington Management Group LLP48.8K1.70%−10.2KMay 15, 2026
Boothbay Fund Management, LLC42.1K1.46%−5.9KMay 15, 2026
Balyasny Asset Management L.P.40.0K1.39%0May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Integrated Core Strategies (US) LLC9.60%103.0K13GFeb 24, 2026
Orin Hirschman9.10%250.0K13GJul 27, 2026
BlackRock, Inc.6.80%187.8K13GJul 30, 2026
Boone Peter David Mr6.40%68.2K13GNov 24, 2025
ADAR1 Capital Management, LLC5.40%58.0K13GFeb 17, 2026
AWM Investment Company, Inc.5.10%147.0K13GAug 14, 2026
Citadel Advisors LLC5.10%70.0K13GMay 15, 2026

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Oct 6, 2025
Parkman Healthcare Partners LLC10 percent owner
Sale · 2 lots257$19.141,050
Oct 6, 2025
Parkman Healthcare Partners LLC10 percent owner
Purchase256$17.911,307

CongressHouse and Senate disclosures

Not reported.